Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-10-11

FDA Approved: COLESEVELAM HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)

View source ↗

Summary

The FDA approved a supplemental application for Colesevelam hydrochloride from Amneal Pharmaceuticals of New York LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Colesevelam hydrochloride (Colesevelam hydrochloride)

Snippet

SUPPL AP for COLESEVELAM HYDROCHLORIDE (COLESEVELAM HYDROCHLORIDE)